Literature DB >> 23580916

S100B protein in tissue development, repair and regeneration.

Guglielmo Sorci1, Francesca Riuzzi, Cataldo Arcuri, Claudia Tubaro, Roberta Bianchi, Ileana Giambanco, Rosario Donato.   

Abstract

The Ca(2+)-binding protein of the EF-hand type, S100B, exerts both intracellular and extracellular regulatory activities. As an intracellular regulator, S100B is involved in the regulation of energy metabolism, transcription, protein phosphorylation, cell proliferation, survival, differentiation and motility, and Ca(2+) homeostasis, by interacting with a wide array of proteins (i.e., enzymes, enzyme substrates, cytoskeletal subunits, scaffold/adaptor proteins, transcription factors, ubiquitin E3 ligases, ion channels) in a restricted number of cell types. As an extracellular signal, S100B engages the pattern recognition receptor, receptor for advanced glycation end-products (RAGE), on immune cells as well as on neuronal, astrocytic and microglial cells, vascular smooth muscle cells, skeletal myoblasts and cardiomyocytes. However, RAGE may not be the sole receptor activated by S100B, the protein being able to enhance bFGF-FGFR1 signaling by interacting with FGFR1-bound bFGF in particular cell types. Moreover, extracellular effects of S100B vary depending on its local concentration. Increasing evidence suggests that at the concentration found in extracellular fluids in normal physiological conditions and locally upon acute tissue injury, which is up to a few nM levels, S100B exerts trophic effects in the central and peripheral nervous system and in skeletal muscle tissue thus participating in tissue homeostasis. The present commentary summarizes results implicating intracellular and extracellular S100B in tissue development, repair and regeneration.

Entities:  

Keywords:  Cell differentiation; Cell motility; Cell proliferation; Cell survival; Development; S100B; Tissue homeostasis; Tissue regeneration; Tissue repair

Year:  2013        PMID: 23580916      PMCID: PMC3622753          DOI: 10.4331/wjbc.v4.i1.1

Source DB:  PubMed          Journal:  World J Biol Chem        ISSN: 1949-8454


  113 in total

1.  Neurotrophic activity of S-100 beta in cultures of dorsal root ganglia from embryonic chick and fetal rat.

Authors:  L J Van Eldik; B Christie-Pope; L M Bolin; E M Shooter; W O Whetsell
Journal:  Brain Res       Date:  1991-03-01       Impact factor: 3.252

2.  S100B stimulates myoblast proliferation and inhibits myoblast differentiation by independently stimulating ERK1/2 and inhibiting p38 MAPK.

Authors:  Francesca Riuzzi; Guglielmo Sorci; Rosario Donato
Journal:  J Cell Physiol       Date:  2006-05       Impact factor: 6.384

3.  Interaction of developmental transcription factor HOXC11 with steroid receptor coactivator SRC-1 mediates resistance to endocrine therapy in breast cancer [corrected].

Authors:  Marie McIlroy; Damian McCartan; Sarah Early; Peadar O Gaora; Stephen Pennington; Arnold D K Hill; Leonie S Young
Journal:  Cancer Res       Date:  2010-02-09       Impact factor: 12.701

4.  The calcium-binding protein S100B down-regulates p53 and apoptosis in malignant melanoma.

Authors:  Jing Lin; Qingyuan Yang; Paul T Wilder; France Carrier; David J Weber
Journal:  J Biol Chem       Date:  2010-06-29       Impact factor: 5.157

5.  A novel role for the Receptor for Advanced Glycation End-products in neural progenitor cells derived from adult SubVentricular Zone.

Authors:  Vasco Meneghini; Maria Teresa Francese; Lorenzo Carraro; Mariagrazia Grilli
Journal:  Mol Cell Neurosci       Date:  2010-06-17       Impact factor: 4.314

6.  S100B Protein, A Damage-Associated Molecular Pattern Protein in the Brain and Heart, and Beyond.

Authors:  Guglielmo Sorci; Roberta Bianchi; Francesca Riuzzi; Claudia Tubaro; Cataldo Arcuri; Ileana Giambanco; Rosario Donato
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-08-18

7.  Inhibiting S100B restores p53 levels in primary malignant melanoma cancer cells.

Authors:  Jing Lin; Qingyuan Yang; Zhe Yan; Joseph Markowitz; Paul T Wilder; France Carrier; David J Weber
Journal:  J Biol Chem       Date:  2004-06-03       Impact factor: 5.157

8.  S100A1 and S100B, transcriptional targets of SOX trio, inhibit terminal differentiation of chondrocytes.

Authors:  Taku Saito; Toshiyuki Ikeda; Kozo Nakamura; Ung-il Chung; Hiroshi Kawaguchi
Journal:  EMBO Rep       Date:  2007-03-30       Impact factor: 8.807

9.  Annexin V, annexin VI, S100A1 and S100B in developing and adult avian skeletal muscles.

Authors:  C Arcuri; I Giambanco; R Bianchi; R Donato
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

10.  HOXC6 and HOXC11 increase transcription of S100beta gene in BrdU-induced in vitro differentiation of GOTO neuroblastoma cells into Schwannian cells.

Authors:  Xiuru Zhang; Jun-ichi Hamada; Arata Nishimoto; Yoko Takahashi; Taichi Murai; Mitsuhiro Tada; Tetsuya Moriuchi
Journal:  J Cell Mol Med       Date:  2007 Mar-Apr       Impact factor: 5.310

View more
  36 in total

1.  Role of biomarkers in the diagnosis of mild traumatic brain injury.

Authors:  Giuseppe Lippi; Gianfranco Cervellin; Yvonne W Lui
Journal:  Radiology       Date:  2013-08       Impact factor: 11.105

2.  Normal cerebellar development in S100B-deficient mice.

Authors:  Björn Bluhm; Björn Laffer; Daniela Hirnet; Matthias Rothermundt; Oliver Ambree; Christian Lohr
Journal:  Cerebellum       Date:  2015-04       Impact factor: 3.847

3.  Response.

Authors:  Yvonne W Lui
Journal:  Radiology       Date:  2013-08       Impact factor: 11.105

4.  Adult vascular smooth muscle cells in culture express neural stem cell markers typical of resident multipotent vascular stem cells.

Authors:  Eimear Kennedy; Ciaran J Mooney; Roya Hakimjavadi; Emma Fitzpatrick; Shaunta Guha; Laura E Collins; Christine E Loscher; David Morrow; Eileen M Redmond; Paul A Cahill
Journal:  Cell Tissue Res       Date:  2014-07-04       Impact factor: 5.249

5.  Myelinated and unmyelinated nerve fibers reinnervate tissue-engineered dermo-epidermal human skin analogs in an in vivo model.

Authors:  T Biedermann; A S Klar; S Böttcher-Haberzeth; E Reichmann; M Meuli
Journal:  Pediatr Surg Int       Date:  2016-09-20       Impact factor: 1.827

6.  Altered cerebrospinal fluid proteins in Smith-Lemli-Opitz syndrome patients.

Authors:  Stephanie M Cologna; Christine Shieh; Cynthia L Toth; Antony Cougnoux; Kathryn R Burkert; Simona E Bianconi; Christopher A Wassif; Forbes D Porter
Journal:  Am J Med Genet A       Date:  2016-05-05       Impact factor: 2.802

7.  Is serum S100B protein an useful biomarker in migraine?

Authors:  Asuman Celikbilek; Seda Sabah; Nermin Tanik; Hakan Ak; Tugay Atalay; Neziha Yilmaz
Journal:  Neurol Sci       Date:  2014-02-16       Impact factor: 3.307

Review 8.  Neuron specific enolase: a promising therapeutic target in acute spinal cord injury.

Authors:  Azizul Haque; Swapan K Ray; April Cox; Naren L Banik
Journal:  Metab Brain Dis       Date:  2016-02-05       Impact factor: 3.584

Review 9.  Molecular Characteristics of RAGE and Advances in Small-Molecule Inhibitors.

Authors:  Hyeon Jin Kim; Mi Suk Jeong; Se Bok Jang
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

10.  A human isogenic iPSC-derived cell line panel identifies major regulators of aberrant astrocyte proliferation in Down syndrome.

Authors:  Keiji Kawatani; Toshihiko Nambara; Nobutoshi Nawa; Hidetaka Yoshimatsu; Haruna Kusakabe; Katsuya Hirata; Akira Tanave; Kenta Sumiyama; Kimihiko Banno; Hidetoshi Taniguchi; Hitomi Arahori; Keiichi Ozono; Yasuji Kitabatake
Journal:  Commun Biol       Date:  2021-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.